Pamer C - Search Results

1

Analysis of Maryland poisoning deaths using classification and regression tree (CART) analysis.

Pamer C, Serpi T, Finkelstein J. Pamer C, et al. AMIA Annu Symp Proc. 2008 Nov 6;2008:550-4. AMIA Annu Symp Proc. 2008. PMID: 18999168 Free PMC article.

2

Retrospective analysis of mortalities associated with medication errors.

Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, Pamer C. Phillips J, et al. Among authors: pamer c. Am J Health Syst Pharm. 2001 Oct 1;58(19):1835-41. doi: 10.1093/ajhp/58.19.1835. Am J Health Syst Pharm. 2001. PMID: 11596700

3

Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.

Ly T, Pamer C, Dang O, Brajovic S, Haider S, Botsis T, Milward D, Winter A, Lu S, Ball R. Ly T, et al. Among authors: pamer c. J Biomed Inform. 2018 Jul;83:73-86. doi: 10.1016/j.jbi.2018.05.019. Epub 2018 Jun 1. J Biomed Inform. 2018. PMID: 29860093 Free article.

4

Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system.

Han L, Ball R, Pamer CA, Altman RB, Proestel S. Han L, et al. Among authors: pamer ca. J Am Med Inform Assoc. 2017 Sep 1;24(5):913-920. doi: 10.1093/jamia/ocx022. J Am Med Inform Assoc. 2017. PMID: 28371826 Free PMC article.

5

Postmarketing surveillance of suicidal adverse events with pediatric use of antidepressants.

Mosholder AD, Pamer CA. Mosholder AD, et al. Among authors: pamer ca. J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):33-6. doi: 10.1089/cap.2006.16.33. J Child Adolesc Psychopharmacol. 2006. PMID: 16553527

6

Changes in ciprofloxacin utilization as shown in a large pharmacy claims database: effects of proximity to criminal anthrax exposure in October 2001.

Brinker A, Pamer C, Beitz J. Brinker A, et al. Among authors: pamer c. J Am Pharm Assoc (2003). 2003 May-Jun;43(3):375-8. doi: 10.1331/154434503321831085. J Am Pharm Assoc (2003). 2003. PMID: 12836787

7

Tardive dyskinesia risks and metoclopramide use before and after U.S. market withdrawal of cisapride.

Shaffer D, Butterfield M, Pamer C, Mackey AC. Shaffer D, et al. Among authors: pamer c. J Am Pharm Assoc (2003). 2004 Nov-Dec;44(6):661-5. doi: 10.1331/1544345042467191. J Am Pharm Assoc (2003). 2004. PMID: 15637848

8

Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts.

Pierce CE, Bouri K, Pamer C, Proestel S, Rodriguez HW, Van Le H, Freifeld CC, Brownstein JS, Walderhaug M, Edwards IR, Dasgupta N. Pierce CE, et al. Among authors: pamer c. Drug Saf. 2017 Apr;40(4):317-331. doi: 10.1007/s40264-016-0491-0. Drug Saf. 2017. PMID: 28044249 Free PMC article.

9

Validating a Framework for Coding Patient-Reported Health Information to the Medical Dictionary for Regulatory Activities Terminology: An Evaluative Study.

Brajovic S, Blaser DA, Zisk M, Caligtan C, Okun S, Hall M, Pamer CA. Brajovic S, et al. Among authors: pamer ca. JMIR Med Inform. 2018 Aug 21;6(3):e42. doi: 10.2196/medinform.9878. JMIR Med Inform. 2018. PMID: 30131314 Free PMC article.

10

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, Mosholder AD. Pamer CA, et al. Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):158-74. doi: 10.1002/pds.1886. Pharmacoepidemiol Drug Saf. 2010. PMID: 20049836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters